News

Biotech vs COVID-19

Biotech vs COVID-19

BioIDEA and EVQLV are hosting a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19. Join us on Thursday, 5/14 at 4 PM EST for a panel discussion on the role of emerging technologies in the fight against COVID-19. If you'd...

read more
EVQLV Wins Columbia Venture Competition

EVQLV Wins Columbia Venture Competition

EVQLV is excited to announce we took first place in Columbia Engineering's Venture Competition (CVC). We've included a snippet from the announcement below. If you'd like to read the official release, you can do so here. In the Technology Challenge, avoMD and EVQLV...

read more
Brett Averso on the AI Podcast in 26.1 Minutes

Brett Averso on the AI Podcast in 26.1 Minutes

Our very own Brett Averso (CTO, EVQLV) was welcomed on the AI Podcast in 26.1 Minutes with hosts Brian Ray and Don Sheu. They discussed our work on COVID-19, the benefits of a computational approach to antibody research and drug discovery, our progress as a company...

read more

EVQLV Featured in insideBIGDATA

Our work on COVID-19 antibodies was covered by insideBIGDATA. They did a fantastic job covering the piece originally published by Columbia Data Science Institute, highlighting a few choice gems. What our algorithms do is reduce the likelihood of drug-discovery failure...

read more

Pin It on Pinterest